Bleeding News and Research

RSS

Genetic testing can improve safety of common blood thinner, study shows

Warfarin is a blood thinner that is commonly prescribed to patients to prevent life-threatening blood clots. Despite its longtime use, warfarin remains tricky to dose because a person's genetic makeup influences how the drug is processed in the body.

27 Sep 2017

Immune cells may play crucial role in helping the brain heal after hemorrhage or stroke

While immune cells called neutrophils are known to act as infantry in the body's war on germs, a National Institutes of Health-funded study suggests they can act as medics as well. By studying rodents, researchers showed that instead of attacking germs, some neutrophils may help heal the brain after an intracerebral hemorrhage, a form of stroke caused by ruptured blood vessels.

20 Sep 2017

Cancer patients less likely to receive evidence-based treatments for heart attack

Treatment of heart attack patients depends on their history of cancer, according to research published today in European Heart Journal: Acute Cardiovascular Care.

20 Sep 2017

Common sense concerns over Nerf gun eye injuries from doctors

Thousands of children worldwide play with Nerf guns. Doctors are now concerned about the potential for these guns to harm the eyes and lead to serious eye injuries.

19 Sep 2017

Continuous glucose monitoring for pregnant women with type 1 diabetes reduces risk of complications for newborns

For women with type 1 diabetes, monitoring blood sugar levels continuously during pregnancy via an implanted device helps better manage the disease, and improves birth outcomes compared to traditional finger-prick tests, according to a new randomized trial published in The Lancet and presented at the European Association for the Study of Diabetes conference.

18 Sep 2017

Know your body and stay informed for prevention of gynecologic cancers

Gynecologic cancers affect any area of the female reproductive organs (uterus, cervix, ovaries, vulva). For 2017, the American Cancer Society estimates more than 100,000 new cases of gynecologic cancer and more than 31,000 deaths. Luckily these organs are either visible or can give early symptoms of pre-cancer and cancer.

15 Sep 2017

Quality-improvement initiative could enhance safety of newborns, provide significant savings

Sick newborns often rely on a ventilator to supply oxygen and are tethered to the life-saving device by a plastic endotracheal tube. The American Academy of Pediatrics has counseled health care providers that ordering a chest X-ray daily simply to verify positioning of the ETT ratchets up costs without improving patient safety.

15 Sep 2017

Prevention experts propose easing advice on number of cervical cancer screenings

Don't get two when one will do. Instead of getting both a Pap test and an HPV test to screen for cervical cancer, many women should get just one or the other at regular intervals, according to a draft recommendation published this week by a panel of prevention experts.

15 Sep 2017

FDA grants approval for new biosimilar to treat multiple types of cancer

The U.S. Food and Drug Administration today approved Mvasi (bevacizumab-awwb) as a biosimilar to Avastin (bevacizumab) for the treatment of multiple types of cancer. Mvasi is the first biosimilar approved in the U.S. for the treatment of cancer.

14 Sep 2017

Modified blood thinner may be first promising method to prevent repercussions after TBI

A chemically modified version of the common blood thinner heparin may be the first promising method of preventing the harmful cascade of destruction to brain tissue that commonly follows traumatic brain injury (TBI), according to new research findings.

13 Sep 2017

New guidelines explain how to reduce delays in endometriosis diagnosis

The National Institute for Health and Care Excellence (NICE) has released guidelines aimed to raise awareness amongst healthcare professionals about delayed diagnosis being a significant problem for women who have endometriosis.

6 Sep 2017

FDA approves drug to treat patients with newly diagnosed CD33-positive AML

The U.S. Food and Drug Administration today approved Mylotarg (gemtuzumab ozogamicin) for the treatment of adults with newly diagnosed acute myeloid leukemia whose tumors express the CD33 antigen (CD33-positive AML).

1 Sep 2017

Pfizer receives FDA approval for new therapy to treat adults and children with AML

Pfizer Inc. today announced that the U.S. Food and Drug Administration approved MYLOTARG (gemtuzumab ozogamicin) for adults with newly diagnosed CD33-positive acute myeloid leukemia (AML), and adults and children 2 years and older with relapsed or refractory CD33-positive AML.

1 Sep 2017

50% of men struggle to identify a woman’s vagina correctly on a diagram: Survey

A recent survey by a gynaecological cancer charity has shown that nearly half of the men could not identify a woman’s vagina correctly on a diagram.

31 Aug 2017

Study explores periodontal status of patients with Chédiak-Higashi syndrome

The International and American Associations for Dental Research have published an article titled "Periodontitis in Chédiak-Higashi Syndrome: An Altered Immunoinflammatory Response" in the JDR Clinical & Translational Research.

31 Aug 2017

$Novartis gets FDA approval for novel immunocellular therapy to treat relapsed or refractory B-cell ALL$

Novartis gets FDA approval for novel immunocellular therapy to treat relapsed or refractory B-cell ALL

Novartis announced today that the US Food and Drug Administration has approved Kymriah (tisagenlecleucel) suspension for intravenous infusion, formerly CTL019, the first chimeric antigen receptor T cell (CAR-T) therapy, for the treatment of patients up to 25 years of age with B-cell precursor acute lymphoblastic leukemia (ALL) that is refractory or in second or later relapse.

30 Aug 2017

Melanomas mostly from from new spots rather than existing ones

According to a new study appearing this week in the Journal of the American Academy of Dermatology, melanomas do not grow from existing moles and skin growths, but from new ones. Therefore it is vital that people keep a careful eye for new growths over their skin in order to detect early stages of melanomas.

29 Aug 2017

IBS scientists uncover key regulator of normal as well as pathological angiogenesis

New blood vessels branch out of preexisting ones is via a process called angiogenesis. Although this is essential for survival, development and wound healing, on the flip side, it also feeds and progresses malignant tumors, as well as other diseases.

29 Aug 2017

Pre-hospital antiplatelet therapy offers no advantages for heart attack patients, study suggests

In contrast to European and American guidelines that recommend pre-hospital antiplatelet therapy for heart attack patients suffering from ST-elevation myocardial infarction (STEMI), a new study presented at ESC Congress1 suggests this practice has no advantage over waiting for in-ho

29 Aug 2017

Intensive Care Medicine

Intensive care medicine is a young specialty that deals with the medical treatment of the sickest patients in the hospital. Intensive care medicine doctors are called intensivists and are expert physicians with special skills in the management of organ failure.

29 Aug 2017

Bleeding News and Research

Genetic testing can improve safety of common blood thinner, study shows

Immune cells may play crucial role in helping the brain heal after hemorrhage or stroke

Cancer patients less likely to receive evidence-based treatments for heart attack

Common sense concerns over Nerf gun eye injuries from doctors

Continuous glucose monitoring for pregnant women with type 1 diabetes reduces risk of complications for newborns

Know your body and stay informed for prevention of gynecologic cancers

Quality-improvement initiative could enhance safety of newborns, provide significant savings

Prevention experts propose easing advice on number of cervical cancer screenings

FDA grants approval for new biosimilar to treat multiple types of cancer

Modified blood thinner may be first promising method to prevent repercussions after TBI

New guidelines explain how to reduce delays in endometriosis diagnosis

FDA approves drug to treat patients with newly diagnosed CD33-positive AML

Pfizer receives FDA approval for new therapy to treat adults and children with AML

50% of men struggle to identify a woman’s vagina correctly on a diagram: Survey

Study explores periodontal status of patients with Chédiak-Higashi syndrome

Novartis gets FDA approval for novel immunocellular therapy to treat relapsed or refractory B-cell ALL

Melanomas mostly from from new spots rather than existing ones

IBS scientists uncover key regulator of normal as well as pathological angiogenesis

Pre-hospital antiplatelet therapy offers no advantages for heart attack patients, study suggests

Intensive Care Medicine

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News